Solasia Pharma KK
TSE:4597
Solasia Pharma KK
Interest Income Expense
Solasia Pharma KK
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Solasia Pharma KK
TSE:4597
|
Interest Income Expense
¥5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Interest Income Expense
-¥548.9m
|
CAGR 3-Years
-105%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-88%
|
|
PeptiDream Inc
TSE:4587
|
Interest Income Expense
-¥2.4B
|
CAGR 3-Years
-164%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Interest Income Expense
¥202m
|
CAGR 3-Years
26%
|
CAGR 5-Years
102%
|
CAGR 10-Years
4%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Interest Income Expense
¥117k
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
S
|
StemRIM Inc
TSE:4599
|
Interest Income Expense
¥587k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
142%
|
CAGR 10-Years
N/A
|
See Also
What is Solasia Pharma KK's Interest Income Expense?
Interest Income Expense
5m
JPY
Based on the financial report for Dec 31, 2023, Solasia Pharma KK's Interest Income Expense amounts to 5m JPY.